novo-nordisk-wegovy-offensive - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,839 +0.83%

DJIA 48,339 +0.90%

Nasdaq 25,091 +0.79%

DAX 23,928 -0.15%

Gold $4,196 +0.16%

Oil $95.75 -0.97%

BTC $72,426 +1.48%

VIX 20.43 -15.85%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

S&P 500 6,839 +0.83%

DJIA 48,339 +0.90%

Nasdaq 25,091 +0.79%

DAX 23,928 -0.15%

Gold $4,196 +0.16%

Oil $95.75 -0.97%

BTC $72,426 +1.48%

VIX 20.43 -15.85%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

novo-nordisk-wegovy-offensive

Novo Nordisk Wegovy Strategy illustrated with GLP-1 injection pen and obesity pill on clinical desk

Pharma & Healthcare·Stocks·Europe

Novo Nordisk Wegovy Strategy Boom With HD Dose Push

By Maik Kemper • Apr 7, 2026

Novo Nordisk Wegovy Strategy illustrated with GLP-1 injection pen and obesity pill on clinical desk

Pharma & Healthcare·Stocks·Europe

Novo Nordisk Wegovy Strategy Boom With HD Dose Push

By Maik Kemper • Apr 7, 2026

Can Novo Nordisk’s aggressive Wegovy strategy really outflank Eli Lilly in the GLP-1 obesity war before new rivals scale up? Maik Kemper Editor in Chief…